Home β€Ί Healthcare β€Ί Biotechnology β€Ί Middle East and Africa Nuclear Medicine Market

Middle East and Africa Nuclear Medicine Market Size, Share, Opportunities, And Trends By Technology (PET, SPECT), By Application (Central Nervous System, Endocrine, Skeletal, Gastrointestinal, Genitourinary, Pulmonary), By End User (Hospitals, Diagnostic Centres, Research Institutions), And By Geography - Forecasts From 2022 To 2027

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,350
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Report Overview

The Middle East and Africa Nuclear medicine Market was valued at US$X.XX billion in 2020 and is projected to expand at a CAGR of XX.XX% over the forecast period to reach US$X.XX billion by 2027. This research study examines the nuclear medicine market on the basis of various segments. Major drivers, restraints, and opportunities have been mentioned to provide an exhaustive picture of the market. Furthermore, the current market trends related to the demand, supply, and sales, in addition to the recent developments, have been provided in this report.  The report also analyzes key players in the nuclear medicine market. The report provides comprehensive forecast up to the period 2022 for various key segments, with 2016 as base year.        

The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical segments. Moreover, the research study analyzes the overall regulatory framework of the Middle East and Africa nuclear medicine market, offering stakeholders a better understanding of the key factors affecting the overall market environment.

The first step towards determining the nuclear medicine market size involves identifying key players and the revenue contribution of the overall business or relevant segment aligned to the study in consideration through extensive secondary research. This also includes various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others. Both bottom-up and top down approaches are utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the nuclear medicine value chain, who are C-Level Executives, Directors, and Managers among others across key enterprises operating as manufacturers, suppliers, and distributors. The last phase is providing intelligence in the form of presentation, charts, graphics and other different formats helping the clients in faster and efficient understanding of the market. Under this phase complete market engineering is involved which includes analyzing the gathered data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Segments covered under the nuclear medicine market report are as below:

By Applications

SPECT Market

PET Market

 

By Procedures

Central Nervous System

Endocrine

Skeletal

Gastrointestinal

Genito-urinary

Pulmonary

 

By End-User Industry

Hospitals

Diagnostic centers

Research Institutes

 

By Geography

Middle East and Africa

UAE

Israel

Qatar

Others

 

Key industry players profiled as part of this section are BRACCO PHARMA, Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Fujifilm Holdings Corporation, GE Healthcare (Subsidiary of General Electric Company), Nordion, Inc., and Taiyo Nippon Sanso Corporation among few others.  

 The report’s target audience is as below:

Manufacturers

Suppliers

Distributors

Service Providers

Government Agencies

Research Organizations

Consultants

REPORT DETAILS

Report ID:KSI061610988
Published:Mar 2021
Pages:114
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us

Frequently Asked Questions

The Middle East and Africa Nuclear Medicine Size, Share, Opportunities, And Trends By Technology (PET, SPECT), By Application (Central Nervous System, Endocrine, Skeletal, Gastrointestinal, Genitourinary, Pulmonary), By End User (Hospitals, Diagnostic Centres, Research Institutions), And By Geography - Forecasts From 2022 To 2027 Market is expected to reach significant growth by 2030.

Key drivers include increasing demand across industries, technological advancements, favorable government policies, and growing awareness among end-users.

This report covers North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa with detailed country-level analysis.

This report provides analysis and forecasts from 2025 to 2030.

The report profiles leading companies operating in the market including major industry players and emerging competitors.

Related Reports

Healthcare

Pre-Clinical CRO Market Size, Share, Opportunities, and Trends By Service Type (Toxicology Testing, Pharmacokinetics & Pharmacodynamics, Safety Pharmacology, Bioanalytical Services, In Vitro Testing, In Vivo Models), By Drug Type (Biologics, Vaccines, Small Molecules, Cell/Gene Therapies), By Therapeutic Area (Oncology, CNS Disorders, Infectious Diseases, Cardiovascular Diseases, Metabolic Disorders, Rare Diseases, Others), By End-User (Biotech Startups, Large Pharma, Medical Device Companies, Academic/Government Institutes), And By Geography – Forecasts From 2025 To 2030

May 2025
Healthcare

Clinical CRO Market Size, Share, Opportunities, And Trends By Clinical Phase (Phase I Trials, Phase II Trials, Phase III Trials, Phase IV [Post-Marketing Surveillance]), By Therapeutic Area (Oncology, CNS, Cardiovascular, Infectious Diseases, Immunology, Metabolic Disorders, Rare Diseases, Others), By Service Category (Clinical Operations And Monitoring, Data And Analytics, Regulatory And Safety, Real-World Evidence [RWE] & Health Economics Outcomes Research [HEOR]), By Client Type (Large Pharma, Small & Mid Biotech, Medical Device Companies, Government And Academic Institutes, CDMOs), And By Geography – Forecasts From 2025 To 2030

May 2025
Healthcare

Industrial Biotechnology Market Size, Share, Opportunities, And Trends By Technology (Fermentation, Genetic Engineering, Others), By Raw Materials (Enzymes, Microorganisms, Bacteria, Yeast, Others), By Application (Biofuel, Biopolymer, Biochemicals, Biomedicines, Others), By End-User (Pharmaceutical, Food & Beverage, Chemical, Energy & Power, Textiles, Others), And By Geography – Forecasts From 2025 To 2030

May 2025
Healthcare

Botulinum Toxins Market - Strategic Insights and Forecasts (2025-2030)

Jan 2026
View All Reports